Preparing service availability
Loading related services
Lahalak Medical PlatformDifferentiate Care
NPM1 Mutation Analysis by PCR
An advanced molecular test for risk stratification in Acute Myeloid Leukemia (AML) patients, helping clinicians choose optimal treatments and monitor minimal residual disease effectively.
An advanced molecular test detecting NPM1 gene mutations. It is essential for risk stratification in AML patients and monitoring minimal residual disease (MRD) following clinical therapy.
Short answers to the FAQs published with this service.
Reference material and files associated with this service when available.
Each provider has one service price, then you choose from its available branches.
Use Labeeb smart tools to understand reports related to (Medical Laboratories), or search the platform directory directly.
We can help request the service and prepare your inquiry, or you can ask Labeeb to guide you to the most suitable category or service.
Related services
